Pharmaceuticals

Aubrey Silberston and Christopher P. Raymond
Additional contact information
Aubrey Silberston: Imperial College of Science, Technology and Medicine
Christopher P. Raymond: Imperial College of Science, Technology and Medicine

Chapter 3 in The Changing Industrial Map of Europe, 1996, pp 43-64 from Palgrave Macmillan

Abstract: Abstract The pharmaceutical industry worldwide is dominated by large firms, many of them with operations in several countries, and many also with a sizeable export trade. In addition there is a large number of smaller firms, often based in one country only, and exporting comparatively little. The division between large and small firms is not the same as that between innovating firms and companies which copy the drugs of other firms. The largest, however, are all innovators, producing brand-name patented drugs. The output of the smallers firms is, by contrast, often of ‘generic’ drugs which are out of patent, and often have no brand name. Several of the large companies have generic subsidiaries.

Keywords: Drug Price; Patent Protection; European Patent Office; Registration Procedure; National Health Authority (search for similar items in EconPapers)
Date: 1996
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-1-349-24357-0_3

Ordering information: This item can be ordered from
http://www.palgrave.com/9781349243570

DOI: 10.1007/978-1-349-24357-0_3

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().